SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-047233
Filing Date
2018-08-16
Accepted
2018-08-16 21:34:20
Documents
1
Period of Report
2018-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2905
  Complete submission text file 0001209191-18-047233.txt   4304
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O ONCOCYTE CORPORATION 1010 ATLANTIC AVENUE, SUITE 102 ALAMEDA CA 94501
Business Address
Parker Albert P (Reporting) CIK: 0001750079 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37648 | Film No.: 181024523